Body distribution of toxic peptides in larvae of a pergid and an argid sawfly species.

Naturwissenschaften

Institute of Condensed Matter and Nanosciences, Université Catholique de Louvain, Place Louis Pasteur 1, 1348, Louvain-la-Neuve, Belgium.

Published: December 2019

Larvae of most Pergidae and Argidae (Symphyta: Tenthredinoidea) species contain toxic peptides such as pergidin and lophyrotomin. Here, larval hemolymph and organs of the pergid Lophyrotoma zonalis and the argid Arge pagana were analysed by liquid chromatography-tandem mass spectrometry. The major identified peptides were pergidin and 4-valinepergidin in L. zonalis, whereas pergidin and lophyrotomin in A. pagana. The storage period prior to chemical analysis was longer for the samples of the pergid than the argid species, which influenced peptide concentrations. In both species, however, the peptides occurred in decreasing order of concentration, first in the hemolymph, then in the integument, while minor amounts of the peptides were detected in other organs such as gut and fat body. By separating the cuticle of the pergid from the remaining integument, the peptides were found in equivalent amounts in each of these two body structures. The results suggest that the peptides play an important role in the defence of these sawfly larvae against predators.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00114-019-1660-7DOI Listing

Publication Analysis

Top Keywords

toxic peptides
8
pergid argid
8
peptides pergidin
8
pergidin lophyrotomin
8
peptides
7
body distribution
4
distribution toxic
4
peptides larvae
4
pergid
4
larvae pergid
4

Similar Publications

The deposition of amyloid-β (Aβ) aggregates and metal ions within senile plaques is a hallmark of Alzheimer's disease (AD). Among the modifications observed in Aβ peptides, -terminal truncation at Phe4, yielding Aβ, is highly prevalent in AD-affected brains and significantly alters Aβ's metal-binding and aggregation profiles. Despite the abundance of Zn(II) in senile plaques, its impact on the aggregation and toxicity of Aβ remains unexplored.

View Article and Find Full Text PDF

Peptide-based amyloid-beta aggregation inhibitors.

RSC Med Chem

December 2024

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Sector 67, S. A. S. Nagar Punjab 160062 India

Aberrant protein misfolding and accumulation is considered to be a major pathological pillar of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Aggregation of amyloid-β (Aβ) peptide leads to the formation of toxic amyloid fibrils and is associated with cognitive dysfunction and memory loss in Alzheimer's disease (AD). Designing molecules that inhibit amyloid aggregation seems to be a rational approach to AD drug development.

View Article and Find Full Text PDF

Na1.7 is considered a promising target for developing next-generation analgesic drugs, given its critical role in human pain pathologies. Although most reported inhibitors with strong in vitro activity and high selectivity share the aryl sulfonamide scaffold, they failed to demonstrate marked clinical efficacy.

View Article and Find Full Text PDF

Background: Closed head injury (CHI) provokes a prominent neuroinflammation that may lead to long-term health consequences. Microglia plays pivotal and complex roles in neuroinflammation-mediated neuronal insult and repair following CHI. We previously reported that induced neural stem cells (iNSCs) can block the effects of CXCL12/CXCR4 signaling on NF-κB activation in activated microglia by CXCR4 overexpression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!